Jin Medical International Ltd. cash flow to debt ratio of 15.35% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Jin Medical International Ltd.'s free cash flow has decreased 59.82% from $-2.33M last year to $-3.73M, signaling decreasing performance

Jin Medical International Ltd.'s debt to equity ratio is 0.68, which means that the company's assets are unhealthy financed, signaling financial risk.

Jin Medical International Ltd.'s debt has increased relative to shareholder equity from 0.40 last year to 0.68 today, signaling weakened financials

Jin Medical International Ltd. has a net cash position, so leverage is healthy.

Jin Medical International Ltd. earns at least as much interest as it pays. Interest obligations are fully covered.

Jin Medical International Ltd.'s profit margin has decreased (61.99%) in the last year from 15.64% to 5.94%, signaling decreasing performance

Jin Medical International Ltd.'s short-term assets of $44.14M exceed its short-term liabilities of $23.80M

Jin Medical International Ltd.'s return on assets of 2.10% is lower than the 5.00% threshold, indicating inefficient asset utilization

Jin Medical International Ltd.'s return on equity of 3.91%, is lower than 15.00%, indicating bad performance

Jin Medical International Ltd.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Jin Medical International Ltd. has insufficient public price history to evaluate earnings stability.

Jin Medical International Ltd. has negative free cash flow, indicating the company is burning cash rather than generating it

Jin Medical International Ltd. has negative free cash flow, indicating cash burn

Jin Medical International Ltd.'s yearly earnings has decreased 67.59% since last year from $3.68M to $1.19M, signaling decreasing performance

Jin Medical International Ltd.'s yearly revenue has decreased 11.98% since last year from $23.50M to $20.69M, signaling decreasing performance

ROIC 0.76% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Jin Medical International Ltd.'s 3-year revenue CAGR of 2.53% is positive, indicating growing revenue over the past 3 years

Jin Medical International Ltd. has insufficient public price history to evaluate revenue consistency.

Jin Medical International Ltd. has insufficient public price history to evaluate ROE consistency.

Jin Medical International Ltd. has insufficient data to evaluate this check.

Jin Medical International Ltd. has an earnings yield of 5.13%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Jin Medical International Ltd. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Jin Medical International Ltd. has an EV/EBITDA ratio of 13.01x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Jin Medical International Ltd. is undervalued relative to its fair value price of 5.47 based on Earnings Fair Value model

Jin Medical International Ltd. has a PEG-ratio over 1 which is considered overvalued

Jin Medical International Ltd. has a price-to-book ratio of 0.76x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Jin Medical International Ltd. has a price-to-sales ratio of 1.16x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue